Back to Search
Start Over
A rank-based randomized phase II design when the phase III design is based on overall survival (OS)
- Source :
- Journal of Clinical Oncology. 32:6597-6597
- Publication Year :
- 2014
- Publisher :
- American Society of Clinical Oncology (ASCO), 2014.
-
Abstract
- 6597 Background: Gan (2013) reported that approximately 27% of 120 randomized phase III trials with a primary endpoint of OS had statistically significant outcomes. Ratain (2005) suggests that the ...
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 32
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........600846f6dd443fc0202a30768df8ed42
- Full Text :
- https://doi.org/10.1200/jco.2014.32.15_suppl.6597